ÂÜÀòÂÒÂ×

Julie joined the company in 2018, as a Study Director specialising in cytogenetics assays. Prior to this, Julie had worked in the Genetic Toxicology Department of a leading pharmaceutical company for 26 years holding positions as a senior cytogeneticist, GLP Study Director and latterly as a Study Monitor. Julie’s current role within Gentronix is as a Study Director for cytogenetic assays and as the Project Licence Holder.